Human skin is a complex multilayered organ. It is the largest organ of the body. As a self-regulating barrier, the skin maintains life, preventing the entry of microorganisms and chemicals into the body and at the same time regulates the loss of heat and water from the body. It is composed of two main layers - epidermis and dermis.
The epidermis is covered by a hydrolipid shell, which is maintained by the secretion of sweat and sebum glands. It helps maintain skin volume and acts as an additional barrier against bacteria and fungi.
The stratum corneum is the outermost layer of the skin, made up of cells whose cytoplasm has been replaced by keratin. Its proper function plays a key role in maintaining skin health, and improper function leads to skin diseases. The stratum corneum consists of corneocytes surrounded by intercellular lipids, including ceramides, free fatty acids, and cholesterol.
Disruption of the epidermal barrier is involved in the pathogenesis of atopic dermatitis. Recent data show its importance in other skin conditions, such as acne vulgaris and rosacea.
In the treatment of these diseases should be properly selected medicinal products, dispensed with or without a prescription, therapeutic moisturizers and cleansers that help maintain the functional and structural integrity of the skin.
The predominant ceramide moisturizers have become the basis for the treatment of skin diseases. New technologies for the delivery of ceramides with multivesicular emulsions delay the ceramides during release continuously and no rupture effect occurs.
Multivesicular emulsion systems are a new patented technology for local delivery of medicinal products. It involves the creation of a two-phase oil-in-water emulsion system that produces concentric multilayer spheres of oil and water. The active ingredients can be released from their respective layers when applied to the skin. In addition to the controlled release of active substances, the multivesicular emulsion base improves the biophysical properties of the skin by reducing transepidermal water loss and improving skin hydration.
Дерматология и венерология. Учебник за студенти по медицина и стоматология. Под редакцията на проф. Асен Дурмишев. Трето преработено и допълнено издание. Медицина и Физкултура София, 2001. Стр. 94
Дерматология и венерология. Учебник за студенти по медицина и стоматология. Под редакцията на проф. Асен Дурмишев. Трето преработено и допълнено издание. Медицина и Физкултура София, 2001. Стр. 167
Дерматология и венерология. Учебник за студенти по медицина и стоматология. Под редакцията на проф. Асен Дурмишев. Трето преработено и допълнено издание. Медицина и Физкултура София, 2001. Стр. 170
Технология на лекарствата. Под редакцията на: Николай Г. Ламбов, Димитър Р. Рачев. София 2019. Глава 20 Полутвърди лекарствени форми. Структура и функция на кожата. Стр. 337
Bikowski J, Shroot B. Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents. J Drugs Dermatol. 2006;5(10):942–946.
Bouwstra JA, Gooris GS, Dubbelaar FER, et al. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res. 1998;39:186–196.
Del Rosso JQ, Levin J. The clinical relevance of maintaining the functional integrity of the statum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol. 2011;4(9):22–42.
Del Rosso JQ. The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. Cutis. 2009;84(2):72–76.
Del Rosso JQ, Zeichner J, Alexis A, et al. Understanding the epidermal barrier in healthy and compromised skin: clinically relevant information for the dermatology practitioner. J Clin Aesthet Dermatol. 2016;9(4):S1–S8.
Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150:1136–1141.
Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis. 2008;81(1):87–91.
Espinoza R Inventor; HealthPoint, LTD, assignee. Multivesicular emulsion drug delivery systems. US Patent 6,709,663. March 23, 2004
Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther. 2004;17:6–15
Levin J, Miller R. A guide to the ingredients and potential benefits of over-the-counter cleansers and moisturizers for rosacea patients. J Clin Aesthet Dermatol. 2011;4(8):31–49.
Lonne-Rahm SB, Fischer T, Berg M. Stinging and Rosacea. Acta Derm Venereol (Stockh). 1999;79(6):460–461.
Lynde CW, Andriessen A, Barankin B, et al. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol. 2014;7(3):18–26.
Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Derm Ther. 2004;17:49–56.
Sajic D, Asiniwasis R, Skotnicki-Grant S. A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramides. Skin Therapy Lett. 2012;17(7):6–9.
Thiboutot D, Del Rosso JQ. Acne vulgaris and the epidermal barrier: is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier? J Clin Aesthet Dermatol. 2013;6(2):18–24.
Torok HM. Rosacea skin care. Cutis. 2000;66(4) Suppl:14–16.
Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res. 1995;287(2):214–218.
Zeichner JA, Patel RV, Haddican M, Wong V. Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris. J Drugs Dermatol. 2012;11(6):748–752.
